BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6774558)

  • 1. Lack of correlation between skin reactivity and T lymphocytes and monocytes in Hodgkin's disease.
    Müftüoğlu AU; Yalçin B
    Acta Haematol; 1980; 63(5):286-8. PubMed ID: 6774558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monocytes in Hodgkin's disease. I. Peripheral blood monocyte count in patients with advanced stages of Hodgkin's disease treated by polychemotherapy and radiotherapy in comparison with a total number of lymphocytes and T lymphocytes].
    Sciborski R
    Pol Arch Med Wewn; 1986 Feb; 75(2):135-41. PubMed ID: 3489225
    [No Abstract]   [Full Text] [Related]  

  • 3. Zinc and anergy in pediatric Hodgkin's disease in Turkey.
    Cavdar AO; Babacan E; Gözdaşoğlu S; Erten J; Cin S; Arcasoy A; Ertem U
    Cancer; 1987 Jan; 59(2):305-9. PubMed ID: 3802017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reed-Sternberg/lymphocyte rosette: lymphocyte subpopulations as defined by monoclonal antibodies.
    Morris CS; Stuart AE
    J Clin Pathol; 1984 Jul; 37(7):767-71. PubMed ID: 6378976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the immunological status of patients with Hodgkin's disease].
    Rambotti P; Velardi A; Spinozzi F; Aversa F; Falini B
    Ann Sclavo; 1978; 20(3):225-38. PubMed ID: 310660
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the high- and low-affinity rosette-forming T-lymphocytes in patients with Hodgkin's and non-Hodgkin's lymphoma.
    Kadhim S; Rees RC; Potter CW; Walker R; Hancock BW
    Eur J Cancer (1965); 1981 May; 17(5):569-75. PubMed ID: 6975211
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunologic parameters in childhood Hodgkin's disease II. T and B lymphocytes in the peripheral blood of normal children and in the spleen and peripheral blood of children with Hodgkin's disease.
    de Sousa M; Tan CT; Siegal FP; Filippa DA; Tan R; Good RA
    Pediatr Res; 1978 Feb; 12(2):143-7. PubMed ID: 306089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivariate analysis of T-cell functional defects and circulating serum factors in Hodgkin's disease.
    Schulof RS; Bockman RS; Garofalo JA; Cirrincione C; Cunningham-Rundles S; Fernandes G; Day NK; Pinsky CM; Incefy GS; Thaler HT; Good RA; Gupta S
    Cancer; 1981 Aug; 48(4):964-73. PubMed ID: 6456060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
    Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
    Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hodgkin's disease in children: investigation of T and B lymphocytes.
    Ilyin NV; Kolygin BA; Letsky VB; Fedoreev GA; Zubzhitsky YN
    Neoplasma; 1978; 25(1):75-81. PubMed ID: 305545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease.
    Fuks Z; Strober S; Bobrove AM; Sasazuki T; McMichael A; Kaplan HS
    J Clin Invest; 1976 Oct; 58(4):803-14. PubMed ID: 135001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of multiple in vivo and in vitro parameters in untreated patients with Hodgkin's disease.
    Case DC; Hansen JA; Corrales E; Young CW; Dupont B; Pinsky CM; Good RA
    Cancer; 1976 Oct; 38(4):1807-15. PubMed ID: 1086708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Disorders of cellular immunity in Hodgkin's disease].
    Burchardt K
    Pol Arch Med Wewn; 1981 Aug; 66(2):133-41. PubMed ID: 7033936
    [No Abstract]   [Full Text] [Related]  

  • 14. Levamisole in the treatment of Hodgkin's disease.
    Berényi E; Kávai M; Szabolcsi M; Szegedi G
    Acta Med Acad Sci Hung; 1979; 36(2):177-85. PubMed ID: 317549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
    Lang JM; Bigel P; Oberling F; Mayer S
    Pathol Biol (Paris); 1978; 26(3-4):159-62. PubMed ID: 355984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
    Lang JM; Bigel P; Oberling F; Mayer S
    Sem Hop; 1978 Nov 8-15; 54(37-40):1155-8. PubMed ID: 217096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune status of untreated patients with Hodgkin's disease and prognosis.
    Björkholm M; Wedelin C; Holm G; Ogenstad S; Johansson B; Mellstedt H
    Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes.
    Hillinger SM; Herzig GP
    J Clin Invest; 1978 Jun; 61(6):1620-7. PubMed ID: 149140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of some immunological parameters in untreated patients with Hodgkin's disease.
    Romagnani S; Amadori A; Maggi E; Biagiotti R; Ricci M
    Int Arch Allergy Appl Immunol; 1977; 55(1-6):429-38. PubMed ID: 145416
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitative and functional abnormalities of total T lymphocytes in relatives of patients with Hodgkin's disease.
    del Giacco GS; Cengiarotti L; Mantovani G; Murgia M; Broccia G; Corda G; di Tucci A
    Eur J Cancer Clin Oncol; 1985 Jul; 21(7):793-801. PubMed ID: 3876218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.